Chinese biopharmaceuticals developer XW Laboratories has raised a $17.5 million Series B funding round led by WI Harper and Elements Capital.
Zai Lab, a Chinese drug developer backed by several venture capital investors, gained 55% on its NASDAQ trading debut following a $150 million IPO.
New Zealand’s Waterman Capital has exited its entire 50% stake in HealthLink, a local online services provider for the healthcare industry, to Ireland-based medical technology specialist Clanwilliam.
After decades of tantalizing but patchy progress, artificial intelligence is finally seen as ready for mass commercialization. Investors must now weigh an unmissable opportunity with a world of uncertainty
Shanghai United Imaging Healthcare, a China-based medical imaging device maker, has completed a RMB3.33 billion ($509 million) Series A round of funding co-led by state-backed SDIC Fund Management and China Life Healthcare Fund.
Shanghai Fosun Pharmaceutical has altered the terms of its acquisition of a majority stake in India-based Gland Pharma – a deal that will facilitate an exit for KKR – as part of a long-running battle to win regulatory approval.
With a $45 million investment from Creador, Indonesian hospital chain Medikaloka Hermina is preparing its push to reach the country's underserved middle class
US-based healthcare specialist investor OrbiMed once again raises the bar with the closing of its oversubscribed third Asia fund
Following a happenstance job placement in healthcare investment, Abrar Mir developed a passion for the sector’s science and ethics. This underpinned the creation of Asia-focused Quadria Capital
Singapore investor Golden Equator Capital and Korean research organization C&R Healthcare Global have jointly launched an incubation program that will help Korean healthcare start-ups execute Asian expansions via Singapore.
The Australian government has agreed to invest A$13.3 million ($11 million) into three local healthcare start-ups via it’s Biomedical Translation Fund (BTF).
WuXi NextCode, a genome sequencing analysis business with ties to China-based contract research organization WuXi PharmaTech, has completed a $240 million extended Series B round of funding led by Sequoia China and featuring Temasek Holdings, Yunfeng...
Creador has committed IDR600 billion ($45 million) to Indonesia-based hospital chain Medikaloka Hermina.
Healthcare-focused investment firm OrbiMed has closed its third Asian private equity fund with $551 million in commitments.
Eight Roads Ventures, the proprietary investment arm of Fidelity International, has launched its debut China healthcare fund worth $250 million. All the capital comes from the firm's parent.
CITIC Private Equity and Chinese drug developer 3SBio – which the PE firm took public in Hong Kong two years ago – have agreed to buy the contract development and manufacturing (CDMO) business of Canada’s Therapure Biopharma for $423 million, including...
IDFC Alternatives has invested INR750 million ($11.7 million) in ASG Eye Hospital, an Indian chain of eye care facilities backed by Sequoia Capital.
TPG Capital has acquired a controlling stake in Taiwan’s OPC Holding, a contract research organization that offers clinical trial services across a number of medical fields.
Australia-based middle market GP Mercury Capital has won regulatory approval to acquire about 50% of Nirvana Health Group, New Zealand’s largest independent primary healthcare services provider.
KKR has acquired a majority stake in cosmetic treatments business Laser Clinics Australia (LCA) at a valuation of A$650 million ($515 million). The deal facilitates a partial exit for The Growth Fund.
BlueRun Ventures and Tencent Holdings have co-led a RMB160 million ($24 million) Series A round of funding for Shuidi, a China-based healthcare services platform that aims to help people pay for medical services.
Goldman Sachs and Hillhouse Capital have jointly invested $90 million in a Series D round of funding for Arrail Dental, a Chinese dental services provider.
Sequoia Capital India and Belgian investor Sofina have led a $30 million Series C round for MedGenome, an India and US-based company focused on molecular biology research and diagnostics.
Indian health and fitness start-up CureFit has raised a $25 million Series B round from a group of investors including Accel Partners and IDG Ventures.